Skip to main content

Chips for Life

Objective

Respiratory tract infections (RTIs) are a huge burden in terms of mortality and morbidity worldwide. To improve the management of the bacterial infections of the respiratory tract, the institution of an appropriate antimicrobial therapy as soon as possible has also been shown to be a key element for reducing morbidity and mortality. The aim of our project is to develop a panel of dedicated rapid diagnostic tests to allow the medical staff to link antibiotic prescription on evidence-based diagnosis. In our 3 year project, combining the Multiplex Ligation-dependent Probe Amplification (MLPA) and microfluidic technologies will allow to address the question of viral or bacterial origin. In the case of a bacteria, a second step will allow to identify which bacteria is of interest with its virulence factors and resistance mechanisms. This new tool will be developed for efficient use in clinical settings in order to allow for a better antibiotic resistance management. Several direct impacts will be observed either on public health (decrease of antibiotic pressure), efficiency of treatment for patients (decrease of infectivity and speed in accurate treatments), for diagnostic laboratories (improve in turn around time), for SMEs (better competitiveness) and more generaly on technological innovations.

Field of science

  • /medical and health sciences/health sciences/public and environmental health
  • /natural sciences/biological sciences/microbiology/bacteriology
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance
  • /social sciences/sociology/demography/mortality

Call for proposal

FP7-HEALTH-2011-two-stage
See other projects for this call

Funding Scheme

CP-FP - Small or medium-scale focused research project
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

CORIS BIOCONCEPT SPRL
Address
Rue Jean Sonet 4A Parc Scientifique Crealys Les Isnes
5032 Gembloux
Belgium
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 552 100
Administrative Contact
Thierry Leclipteux (Dr.)

Participants (7)

IBM RESEARCH GMBH
Switzerland
EU contribution
€ 482 200
Address
Saeumerstrasse 4
8803 Rueschlikon
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Catherine Trachsel (Ms.)
INSERM TRANSFERT SA
France
EU contribution
€ 270 000
Address
Rue Watt 7
75013 Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Sinéad Quigley (Ms.)
MICROFLUIDIC CHIPSHOP GMBH
Germany
EU contribution
€ 594 000
Address
Stockholmer Strasse 20
07747 Jena
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Claudia Gärtner (Dr.)
CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE
Belgium
EU contribution
€ 393 800
Address
Sart Tilman B35
4000 Liege
Activity type
Research Organisations
Administrative Contact
Pierrette Melin (Dr.)
PATHOFINDER HOLDING BV

Participation ended

Netherlands
Address
Randwycksingel 45
6229 EG Maastricht
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Guus Simons (Dr.)
UNIVERSITEIT ANTWERPEN
Belgium
EU contribution
€ 85 200
Address
Prinsstraat 13
2000 Antwerpen
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Anne Adams (Ms.)
PATHOFINDER BV
Netherlands
EU contribution
€ 499 000
Address
Randwycksingel 45
6229 EG Maastricht
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Agustinus F.M. Guus Simons (Dr.)